China National Accord Medicines Corporation Ltd. (SHE:000028)
China · Delayed Price · Currency is CNY 19.47
-0.37 (-1.86%)
Aug 21, 2026, 3:04 PM CST
SHE:000028 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 7,802 | 7,409 | 6,502 | 6,016 | 5,126 |
Cash & Short-Term Investments | 5,179 | 7,802 | 7,409 | 6,502 | 6,016 | 5,126 |
Cash Growth | -23.81% | 5.32% | 13.94% | 8.08% | 17.37% | -18.44% |
Accounts Receivable | - | 22,939 | 21,118 | 20,235 | 16,202 | 17,701 |
Other Receivables | - | 132.22 | 146.41 | 265.56 | 66.85 | 87.26 |
Receivables | - | 23,071 | 21,294 | 20,539 | 16,306 | 17,855 |
Inventory | - | 8,122 | 7,406 | 7,989 | 7,836 | 7,622 |
Other Current Assets | - | 1,200 | 1,467 | 1,340 | 1,550 | 1,246 |
Total Current Assets | - | 40,196 | 37,576 | 36,370 | 31,708 | 31,848 |
Property, Plant & Equipment | - | 2,692 | 3,479 | 3,724 | 3,407 | 3,494 |
Long-Term Investments | - | 3,278 | 3,080 | 2,947 | 2,799 | 2,658 |
Goodwill | - | 1,605 | 1,859 | 2,747 | 2,750 | 2,776 |
Other Intangible Assets | - | 406.69 | 479.54 | 615.59 | 647.52 | 669.93 |
Long-Term Accounts Receivable | - | 1.72 | 12.93 | 15.91 | 13.68 | 16.59 |
Long-Term Deferred Tax Assets | - | 308.72 | 249.41 | 220.48 | 185.25 | 129.74 |
Long-Term Deferred Charges | - | 335.23 | 467.67 | 526.58 | 572.55 | 633.98 |
Other Long-Term Assets | - | 273.09 | 352.1 | 404.42 | 532.4 | 557.38 |
Total Assets | - | 49,096 | 47,556 | 47,571 | 42,616 | 42,784 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | - | 20,516 | 18,100 | 17,952 | 15,233 | 16,718 |
Accrued Expenses | - | 666.7 | 779.14 | 760.58 | 998.17 | 753.2 |
Short-Term Debt | - | 2,855 | 3,422 | 2,903 | 2,133 | 2,490 |
Current Portion of Long-Term Debt | - | - | - | 17 | 45.14 | - |
Current Portion of Leases | - | 740.45 | 944.37 | 1,002 | 867.85 | 848.33 |
Current Income Taxes Payable | - | 171.63 | 128.03 | 205.9 | 237.8 | 178.87 |
Current Unearned Revenue | - | 387.21 | 349.74 | 456.3 | 586.96 | 450.59 |
Other Current Liabilities | - | 768.63 | 1,079 | 1,041 | 926.05 | 939.8 |
Total Current Liabilities | - | 26,105 | 24,802 | 24,338 | 21,028 | 22,379 |
Long-Term Debt | - | - | - | - | 17.5 | 71.64 |
Long-Term Leases | - | 912.18 | 1,371 | 1,452 | 1,327 | 1,375 |
Long-Term Unearned Revenue | - | 69.28 | 69.48 | 74.97 | 80.91 | 87.72 |
Pension & Post-Retirement Benefits | - | 0.61 | 0.71 | 0.77 | 0.86 | 1.2 |
Long-Term Deferred Tax Liabilities | - | 93.87 | 114.5 | 146.05 | 156.48 | 175.95 |
Other Long-Term Liabilities | - | 290.7 | 441.99 | 581.45 | 560.3 | 670.52 |
Total Liabilities | - | 27,472 | 26,800 | 26,593 | 23,171 | 24,761 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | - | 556.57 | 556.57 | 556.57 | 428.13 | 428.13 |
Additional Paid-In Capital | - | 4,268 | 4,261 | 4,261 | 4,357 | 4,372 |
Retained Earnings | - | 13,786 | 12,854 | 12,590 | 11,333 | 10,103 |
Comprehensive Income & Other | - | -0.28 | -1.45 | 7.87 | 7.91 | 21.87 |
Total Common Equity | 18,897 | 18,610 | 17,670 | 17,415 | 16,126 | 14,925 |
Minority Interest | - | 3,015 | 3,086 | 3,563 | 3,319 | 3,097 |
Shareholders' Equity | 21,913 | 21,624 | 20,755 | 20,978 | 19,445 | 18,022 |
Total Liabilities & Equity | - | 49,096 | 47,556 | 47,571 | 42,616 | 42,784 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 4,096 | 4,507 | 5,737 | 5,374 | 4,391 | 4,786 |
Net Cash (Debt) | 1,084 | 3,295 | 1,671 | 1,129 | 1,626 | 340.48 |
Net Cash Growth | 3621.20% | 97.18% | 48.07% | -30.58% | 377.51% | -82.99% |
Net Cash Per Share | 1.77 | 5.38 | 2.72 | 1.84 | 2.66 | 0.56 |
Filing Date Shares Outstanding | 616.52 | 612.22 | 612.22 | 612.22 | 612.22 | 612.22 |
Total Common Shares Outstanding | 616.52 | 612.22 | 612.22 | 612.22 | 612.22 | 612.22 |
Working Capital | - | 14,091 | 12,774 | 12,032 | 10,681 | 9,469 |
Book Value Per Share | 30.87 | 30.40 | 28.86 | 28.45 | 26.34 | 24.38 |
Tangible Book Value | 16,895 | 16,598 | 15,331 | 14,053 | 12,728 | 11,479 |
Tangible Book Value Per Share | 27.60 | 27.11 | 25.04 | 22.95 | 20.79 | 18.75 |
Buildings | - | 806.56 | 807.91 | 741.11 | 738.01 | 725.86 |
Machinery | - | 1,414 | 1,396 | 1,294 | 1,132 | 1,027 |
Construction In Progress | - | 21.66 | 12.6 | 35.44 | 35.17 | 49.85 |